A bicomponent Plasmodium falciparum investigational vaccine composed of proteinpeptide conjugates

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 3, 2010, Pages 1172-1177

  Kubler Kielb, Joanna ^a   Majadly, Fathy ^a   Biesova, Zuzana ^a   Mocca, Christopher P ^a   Guo, Chunyan ^a   Nussenzweig, Ruth ^b   Nussenzweig, Victor ^b   Mishra, Satish ^b   Wu, Yimin ^c   Miller, Louis H ^c   Keith, Jerry M ^a   Liu, Teh Yung ^a   Robbins, John B ^a   Schneerson, Rachel ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Asn Ala Asn Pro; Circumsporozoite protein; Malaria; Plasmodium falciparum ookinete surface protein 25

Indexed keywords

AMINO ACID; ANTIBODY; ASPARAGINYLALANYLASPARAGINYLPROLINE; CARRIER PROTEIN; CIRCUMSPOROZOITE PROTEIN; MALARIA VACCINE; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; PROTEIN PFS25; TETRAPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS; IMMUNITY; IMMUNOFLUORESCENCE; MALARIA; MORTALITY; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SPOROZOITE;

ANIMALS; ANTIBODIES, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MALARIA VACCINES; MICE; PEPTIDES; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; T-LYMPHOCYTES;

AVES; MAMMALIA; MUS; PLASMODIUM FALCIPARUM;

EID: 75749102649     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0913374107     Document Type: Article

References (21)

1. Hay SI, et al. (2009) A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med 6:e1000048.
2. Ladhani S, Aibara RJ, Riordan FA, Shingadia D (2007) Imported malaria in children: a review of clinical studies. Lancet Infect Dis 7:349-357.
3. González A, et al. (2009) Severe imported malaria in adults: retrospective study of 20 cases. Am J Trop Med Hyg 81:595-599.
4. World Health Organization (2000) Severe falciparum malaria. Trans R Soc Trop Med Hyg 94 (Suppl 1):S1-S90.
5. Sherman I (2009) The Exclusive Malaria Vaccine: Miracle or Mirage? (ASM Press, Washington, DC), pp 111-319.
6. Cohen J, Nussenzweig V, Nussenzweig R, Vekemans J, Leach A (2009) From the circumsporozoite protein to the RTS,S/AS candidate vaccine. Hum Vaccin 30:1-7.
7. Stoute JA, et al. (1998) Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine. J Infect Dis 178:1139-1144.
8. Bojang KA, et al. (2001) Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 358:1927-1934.
9. Kubler-Kielb J, et al. (2007) Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25. Proc Natl Acad Sci USA 104:293-298.
10. Nardin EH, Nussenzweig RS (1993) T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Annu Rev Immunol 11:687-727.
11. Breman JG (2001) The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am J Trop Med Hyg 64 (1-2, Suppl):1-11.
12. Murphy SC, Breman JG (2001) Gaps in the childhood malaria burden in Africa: Cerebral malaria, neurological sequelae, anemia, respiratory distress, hypogycemia and complications pregnancy. Am J Trop Med Hyg 64 (1-2, Suppl):57-67.
13. Herrington DA, et al. (1990) Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites. Bull World Health Organ 68 (Suppl):33-37.
14. Sawardeker JS, Sloneker JH, Jeanes AR (1965) Quantitative determination of monosaccharides as their alditol acetates by gas-liquid chromatography. Anal Chem 37:1602-1604.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
16. Tsai CW, Duggan PF, Shimp RL, Jr, Miller LH, Narum DL (2006) Overproduction of Pichia pastoris or Plasmodium falciparum protein disulfide isomerase affects expression, folding and O-linked glycosylation of a malaria vaccine candidate expressed in P. pastoris. J Biotechnol 121:458-470.
17. Bruna-Romero O, Rocha CD, Tsuji M, Gazzinelli RT (2004) Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif. Vaccine 22:3575-3584.
18. Zavala F, Cochrane AH, Nardin EH, Nussenzweig RS, Nussenzweig V (1983) Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes. J Exp Med 157:1947-1957.
19. Taylor DN, et al. (1993) Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids. Infect Immun 61:3678-3687.
20. Wu Y, et al. (2008) Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. PLoS One 3:2636.
21. Nardin EH, Gwadz RW, Nussenzweig RS (1979) Characterization of sporozoite surface antigens by indirect immunofluorescence: detection of stage- and species-specific antimalarial antibodies. Bull World Health Organ 57 (Suppl 1):211-217.